eISSN 2508-3589
pISSN 2508-1926

Table. 3.

Table. 3.

Percentage of oil and air presence and number of silicone oil droplet in agitation and no agitation group, according to the type of syringe

Group p-value

Bevacizumab (Group 1+2) Fluid (Group 3+4)
Presence of oil
Syringe 1 15/20 (75) 11/20 (55) 0.320*
Syringe 2 2/20 (10) 1/20 (5) 1.000*
Syringe 3 10/20 (50) 6/20 (30) 0.333*
Presence of air
Syringe 1 6/20 (30) 5/20 (25) 1.000*
Syringe 2 4/20 (20) 2/20 (10) 0.661*
Syringe 3 7/20 (35) 5/20 (25) 0.731*
Number of silicone oil droplets
Syringe 1 6.4 ± 6.4 4.0 ± 4.6 0.198
Syringe 2 0.3 ± 1.0 0.1 ± 0.4 0.534
Syringe 3 1.3 ± 1.7 0.7 ± 1.2 0.226

Values are presented as mean ± standard deviation or number (%). Syringe 1 = Shinchang Medical Co.; Syringe 2 = Becton, Dickinson; Syringe 3 = Sungshim Medical Co.

*Fisher’s exact test; †Mann-Whitney test.

J Retin 2021;6:75-83 https://doi.org/10.21561/jor.2021.6.2.75
© 2021 J Retin